A prospective randomized safety trial of celecoxib for treatment of preterm labor

Authors :: Stika, Catherine S.
Gross, Gilad A.
Leguizamon, Gustavo
Gerber, Susan
Levy, Roni
Mathur, Amit
Bernhard, Lisa M.
Nelson, D. Michael
Sadovsky, Yoel
Source :: American Journal of Obstetrics and Gynecology. Sept, 2002, Vol. 187 Issue 3, p653, 8 p.
Publication Year :: 2002
Abstract: The COX-2 inhibitor celecoxib may be more effective than indomethacin in stopping premature labor because it has fewer side effects. This was the conclusion of a study of 24 pregnant women in premature labor. Indomethacin has been used to stop premature labor since the 1970s, but it has serious adverse effects on the baby.

Subjects :: Premature labor -- Drug therapy
Celecoxib -- Evaluation
Indomethacin -- Evaluation
Health
Celexa (Medication) -- Evaluation

Tools